中文名 | 坎地沙坦西来替昔乙酯 |
---|---|
英文名 | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
英文别名 |
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester UNII-ZRT0P1L622 2-N-ethyl CNS 2H-2-Ethyl Candesartan Cilexetil Candesartan Cilexetil EP Impurity F ±1-(Cyclohexyloxycarbonyloxy)ethyl2-ethoxy-1-{[2’-(N-ethyl-tetrazol-5-yl) biphenyl-4-yl]methyl}benzimidazole-7-carboxylate Candesartan Cilexetil Impurity 6 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 842.0±75.0 °C at 760 mmHg |
分子式 | C35H38N6O6 |
分子量 | 638.71300 |
闪点 | 463.1±37.1 °C |
精确质量 | 638.28500 |
PSA | 132.48000 |
LogP | 8.08 |
蒸汽压 | 0.0±3.1 mmHg at 25°C |
折射率 | 1.648 |
危险品运输编码 | NONH for all modes of transport |
---|
~% 914613-36-8 |
文献:TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |
~% 914613-36-8 |
文献:Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 |
~% 914613-36-8 |
文献:TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |